Oona Delpuech

2.3k total citations
33 papers, 1.7k citations indexed

About

Oona Delpuech is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Oona Delpuech has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Oona Delpuech's work include Advanced Breast Cancer Therapies (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer-related Molecular Pathways (5 papers). Oona Delpuech is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer-related Molecular Pathways (5 papers). Oona Delpuech collaborates with scholars based in United Kingdom, United States and France. Oona Delpuech's co-authors include Almut Schulze, Julian Downward, B Griffiths, Philip East, Yuen‐Li Chung, John R. Griffiths, Thomas Porstmann, Barrie Peck, Emma C. Ferber and Françoise Carnot and has published in prestigious journals such as Molecular Cell, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Oona Delpuech

33 papers receiving 1.6k citations

Peers

Oona Delpuech

ONCOL

PRM

EPIDE

Guang‐Zhi Jin China

Limei Liu China

Chia‐Lang Hsu Taiwan

Sandrine Boyault France

Haluk Yuzugullu France

Eunice Y. Lau Hong Kong

Mahmut Yilmaz Switzerland

Changwei Dou China

Hong Sug Kim South Korea

Yuezhen Deng China

Guang‐Zhi Jin China

Oona Delpuech

1.2k ×1.1

733 ×1.6

380 ×0.9

ONCOL

228 ×0.9

PRM

200 ×1.0

EPIDE

Citations per year, relative to Oona Delpuech Oona Delpuech (= 1×) peers Guang‐Zhi Jin

Countries citing papers authored by Oona Delpuech

Since Specialization

Citations

This map shows the geographic impact of Oona Delpuech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oona Delpuech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oona Delpuech more than expected).

Fields of papers citing papers by Oona Delpuech

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oona Delpuech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oona Delpuech. The network helps show where Oona Delpuech may publish in the future.

Co-authorship network of co-authors of Oona Delpuech

This figure shows the co-authorship network connecting the top 25 collaborators of Oona Delpuech. A scholar is included among the top collaborators of Oona Delpuech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oona Delpuech. Oona Delpuech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Matthew J., Nicolas Floc’h, Matthias Pfeifer, et al.. (2022). Pharmaceutical Reactivation of Attenuated Apoptotic Pathways Leads to Elimination of Osimertinib Drug-Tolerant Cells. Cancer Research Communications. 2(10). 1312–1325. 6 indexed citations

Kuczynski, Elizabeth A., Giulia Morlino, Anna Coenen-Stass, et al.. (2022). A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability. EMBO Molecular Medicine. 14(6). e15816–e15816. 5 indexed citations

Criscione, Steven W., Matthew J. Martin, Derek B. Oien, et al.. (2022). The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells. npj Precision Oncology. 6(1). 95–95. 22 indexed citations

Clausen, Maryam, Rebecca Halpin, Kang Cai, et al.. (2021). A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce. Scientific Reports. 11(1). 12676–12676. 1 indexed citations

Winkler, C, Matthew King, Domenico Ferraioli, et al.. (2021). SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer. JCI Insight. 6(18). 26 indexed citations

Lynch, James T., Urszula M. Polanska, Oona Delpuech, et al.. (2018). Combined Inhibition of PI3Kβ and mTOR Inhibits Growth of PTEN-null Tumors. Molecular Cancer Therapeutics. 17(11). 2309–2319. 18 indexed citations

Michaloglou, Chrysiis, Claire Crafter, Rasmus Siersbæk, et al.. (2018). Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor–positive Breast Cancer. Molecular Cancer Therapeutics. 17(5). 908–920. 128 indexed citations

Langdon, Sophie, Adina Hughes, Molly A. Taylor, et al.. (2018). Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity. OncoImmunology. 7(8). e1458810–e1458810. 40 indexed citations

Nardone, Agostina, Hazel M. Weir, Oona Delpuech, et al.. (2018). The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance. British Journal of Cancer. 120(3). 331–339. 43 indexed citations

10.

Lynch, James T., Urszula M. Polanska, Oona Delpuech, et al.. (2017). Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors. Clinical Cancer Research. 23(24). 7584–7595. 24 indexed citations

11.

Trinidad, Antonio G., Nicky Whalley, Rachel Rowlinson, et al.. (2017). Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation of mutant KRAS, regulating cell growth in lung and colorectal tumour cells. Oncogene. 36(44). 6164–6176. 23 indexed citations

12.

Delpuech, Oona, Claire Rooney, Lorraine Mooney, et al.. (2016). Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547. Molecular Cancer Therapeutics. 15(11). 2802–2813. 18 indexed citations

13.

Hudson, Kevin, Urs J. Hancox, Cath Trigwell, et al.. (2016). Intermittent High-Dose Scheduling of AZD8835, a Novel Selective Inhibitor of PI3Kα and PI3Kδ, Demonstrates Treatment Strategies for PIK3CA -Dependent Breast Cancers. Molecular Cancer Therapeutics. 15(5). 877–889. 36 indexed citations

14.

Taylor, Molly A., Mark Wappett, Oona Delpuech, Helen Brown, & Christine M. Chresta. (2016). Enhanced MAPK signaling drives ETS1-mediated induction of miR-29b leading to downregulation of TET1 and changes in epigenetic modifications in a subset of lung SCC. Oncogene. 35(33). 4345–4357. 28 indexed citations

15.

Guichard, Sylvie M., Jon Curwen, Teeru Bihani, et al.. (2015). AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules. Molecular Cancer Therapeutics. 14(11). 2508–2518. 103 indexed citations

16.

Bradford, James, Matthew R. Farren, Steve Powell, et al.. (2013). RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib. PLoS ONE. 8(6). e66003–e66003. 24 indexed citations

17.

Sidorkiewicz, M, José Guilherme Tralhão, Serban Morosan, et al.. (2008). Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. World Journal of Gastroenterology. 14(4). 574–574. 7 indexed citations

18.

Delpuech, Oona, B Griffiths, Philip East, et al.. (2007). Induction of Mxi1-SRα by FOXO3a Contributes to Repression of Myc-Dependent Gene Expression. Molecular and Cellular Biology. 27(13). 4917–4930. 145 indexed citations

19.

Porstmann, Thomas, B Griffiths, Yuen‐Li Chung, et al.. (2005). PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene. 24(43). 6465–6481. 368 indexed citations

20.

Delpuech, Oona, Jean‐Baptiste Trabut, Françoise Carnot, et al.. (2002). Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma. Oncogene. 21(18). 2926–2937. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact